1. Home
  2. NMZ vs RXRX Comparison

NMZ vs RXRX Comparison

Compare NMZ & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Municipal High Income Opportunity Fund $0.01 par value per share

NMZ

Nuveen Municipal High Income Opportunity Fund $0.01 par value per share

N/A

Current Price

$8.75

Market Cap

1.9B

Sector

Finance

ML Signal

N/A

Logo Recursion Pharmaceuticals Inc.

RXRX

Recursion Pharmaceuticals Inc.

N/A

Current Price

$3.20

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NMZ
RXRX
Founded
2003
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.2B
IPO Year
2003
2021

Fundamental Metrics

Financial Performance
Metric
NMZ
RXRX
Price
$8.75
$3.20
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
★ $7.32
AVG Volume (30 Days)
1.9M
★ 20.9M
Earning Date
01-01-0001
11-02-2026
Dividend Yield
★ 5.08%
N/A
EPS Growth
N/A
★ 14.79
EPS
★ N/A
N/A
Revenue
N/A
★ $74,681,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$49.16
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 26.92
52 Week Low
$8.62
$2.77
52 Week High
$10.74
$5.24

Technical Indicators

Market Signals
Indicator
NMZ
RXRX
Relative Strength Index (RSI) 41.54 39.34
Support Level $8.67 $2.90
Resistance Level $9.19 $3.66
Average True Range (ATR) 0.13 0.32
MACD 0.01 -0.07
Stochastic Oscillator 12.35 2.22

Price Performance

Historical Comparison
NMZ
RXRX

About NMZ Nuveen Municipal High Income Opportunity Fund $0.01 par value per share

Nuveen Municipal High Income Opp Fund is a diversified, closed-end management investment company. The Fund's primary investment objective is to provide high current income exempt from regular federal income tax. The Fund's secondary investment objective is to seek an attractive total return consistent with its primary objective.

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

Share on Social Networks: